JP2023522630A5 - - Google Patents
Info
- Publication number
- JP2023522630A5 JP2023522630A5 JP2022562446A JP2022562446A JP2023522630A5 JP 2023522630 A5 JP2023522630 A5 JP 2023522630A5 JP 2022562446 A JP2022562446 A JP 2022562446A JP 2022562446 A JP2022562446 A JP 2022562446A JP 2023522630 A5 JP2023522630 A5 JP 2023522630A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063009578P | 2020-04-14 | 2020-04-14 | |
| US63/009,578 | 2020-04-14 | ||
| PCT/EP2021/059646 WO2021209495A1 (en) | 2020-04-14 | 2021-04-14 | Anti-flt3 antibodies and compositions |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2023522630A JP2023522630A (ja) | 2023-05-31 |
| JP2023522630A5 true JP2023522630A5 (https=) | 2024-04-22 |
| JPWO2021209495A5 JPWO2021209495A5 (https=) | 2024-04-22 |
| JP7679399B2 JP7679399B2 (ja) | 2025-05-19 |
Family
ID=75530015
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022562446A Active JP7679399B2 (ja) | 2020-04-14 | 2021-04-14 | 抗ｆｌｔ３抗体及び組成物 |
Country Status (16)
| Country | Link |
|---|---|
| US (2) | US12252539B2 (https=) |
| EP (1) | EP4136114A1 (https=) |
| JP (1) | JP7679399B2 (https=) |
| KR (1) | KR20220167331A (https=) |
| CN (1) | CN115715297A (https=) |
| AU (1) | AU2021255884A1 (https=) |
| BR (1) | BR112022020683A2 (https=) |
| CA (1) | CA3180188A1 (https=) |
| CL (1) | CL2022002833A1 (https=) |
| CO (1) | CO2022014520A2 (https=) |
| IL (1) | IL297269A (https=) |
| MX (1) | MX2022012919A (https=) |
| PE (1) | PE20230075A1 (https=) |
| PH (1) | PH12022552710A1 (https=) |
| TW (1) | TWI910146B (https=) |
| WO (1) | WO2021209495A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI910146B (zh) * | 2020-04-14 | 2026-01-01 | 法商施維雅藥廠 | 抗flt3抗體及組合物 |
| WO2024108163A2 (en) * | 2022-11-18 | 2024-05-23 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Molecules that bind to cd135 polypeptides |
| EP4637816A1 (en) * | 2022-12-22 | 2025-10-29 | The Medical College of Wisconsin, Inc. | Compositions that target cd138 and cd3 and methods of making and using the same |
| IL325858A (en) * | 2023-07-12 | 2026-03-01 | Phenomic Ai | Mediators of T cell activation against CTHRC1 and methods of using them |
| CN118924724B (zh) * | 2024-07-29 | 2025-11-04 | 湖南大学 | 一种用于治疗神经母细胞瘤的药物组合物 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU7832394A (en) | 1993-09-08 | 1995-03-27 | Imclone Systems Incorporated | Monoclonal antibodies that recognize flk-2 receptors and the isolation of primitive hematopoietic stem cell populations |
| US5635388A (en) | 1994-04-04 | 1997-06-03 | Genentech, Inc. | Agonist antibodies against the flk2/flt3 receptor and uses thereof |
| EP1105427A2 (en) | 1998-08-17 | 2001-06-13 | Abgenix, Inc. | Generation of modified molecules with increased serum half-lives |
| MXPA03003632A (es) | 2000-10-24 | 2003-09-10 | Immunex Corp | Metodo para tratamiento de tumores usando terapia de combinacion. |
| AR071891A1 (es) | 2008-05-30 | 2010-07-21 | Imclone Llc | Anticuerpos humanos anti-flt3 (receptor tirosina cinasa 3 tipo fms humano) |
| HRP20160422T1 (hr) * | 2009-12-23 | 2016-05-20 | Synimmune Gmbh | Protutijela protiv flt3 postupci njihove upotrebe |
| CA2961950A1 (en) * | 2014-09-28 | 2016-03-31 | The Regents Of The University Of California | Modulation of stimulatory and non-stimulatory myeloid cells |
| TWI829617B (zh) * | 2015-07-31 | 2024-01-21 | 德商安美基研究（慕尼黑）公司 | Ｆｌｔ３及ｃｄ３抗體構築體 |
| AU2017382883B2 (en) * | 2016-12-21 | 2024-07-04 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Human monoclonal antibodies specific for FLT3 and uses thereof |
| CN118772278A (zh) * | 2017-06-02 | 2024-10-15 | 辉瑞公司 | Flt3的特异性抗体及其用途 |
| JP7317718B2 (ja) * | 2017-06-02 | 2023-07-31 | ファイザー・インク | Ｆｌｔ３を標的にするキメラ抗原受容体 |
| CN113056486B (zh) * | 2018-09-11 | 2025-06-17 | 德国肿瘤研究中心 | 改善的抗flt3抗原结合蛋白 |
| JP7642542B2 (ja) * | 2018-12-18 | 2025-03-10 | ベーリンガー・インゲルハイム・イオ・カナダ・インコーポレイテッド | Ｆｌｔ３アゴニスト抗体及びその使用 |
| TWI910146B (zh) * | 2020-04-14 | 2026-01-01 | 法商施維雅藥廠 | 抗flt3抗體及組合物 |
-
2021
- 2021-04-14 TW TW110113434A patent/TWI910146B/zh active
- 2021-04-14 IL IL297269A patent/IL297269A/en unknown
- 2021-04-14 WO PCT/EP2021/059646 patent/WO2021209495A1/en not_active Ceased
- 2021-04-14 US US17/230,289 patent/US12252539B2/en active Active
- 2021-04-14 BR BR112022020683A patent/BR112022020683A2/pt unknown
- 2021-04-14 PE PE2022002250A patent/PE20230075A1/es unknown
- 2021-04-14 EP EP21718860.6A patent/EP4136114A1/en active Pending
- 2021-04-14 MX MX2022012919A patent/MX2022012919A/es unknown
- 2021-04-14 CN CN202180042192.0A patent/CN115715297A/zh active Pending
- 2021-04-14 AU AU2021255884A patent/AU2021255884A1/en active Pending
- 2021-04-14 PH PH1/2022/552710A patent/PH12022552710A1/en unknown
- 2021-04-14 CA CA3180188A patent/CA3180188A1/en active Pending
- 2021-04-14 KR KR1020227039594A patent/KR20220167331A/ko active Pending
- 2021-04-14 JP JP2022562446A patent/JP7679399B2/ja active Active
-
2022
- 2022-10-13 CO CONC2022/0014520A patent/CO2022014520A2/es unknown
- 2022-10-14 CL CL2022002833A patent/CL2022002833A1/es unknown
-
2025
- 2025-02-07 US US19/048,584 patent/US20250179195A1/en active Pending